Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 29 of TScan Therapeutics, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program and 4 shelf registrations on file for TCRX. The latest dilution event on file is ATM sales on Aug 12, 2026. Analysis updated Oct 4, 2026.
Raise routes on file: effective shelf · latest dilution event 83 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 12, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2023
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2022
Total capacity
Remaining
Total capacity
Remaining
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z